Xconomy | Boston - Business + Technology in the Exponential Economy

After Fending Off Sequenom Takeover, Exact Sciences Replaces CEO and CFO with Diagnostics Vets
New Execs for Exact, Sirtris, and Ischemix; New Deal for Biogen and Aveo; New Money for MedAptus and Claros; & More Boston-Area Life Sciences News
Sequenom Getting Aggressive in Bid to Buy Exact Sciences
Harvard Researcher to Helm Merck’s Cancer Research, Genzyme Acquires Certain Exact Sciences Assets, NeurAxon Out to Axe Migraines, & More Boston-Area Life Sciences
Exact Sciences to Sequenom: No Deal

Exact Sciences Moving to Wisconsin

Exact Sciences (NASDAQ:EXAS), a Marlborough, MA-based provider and developer of DNA tests for colorectal cancer, has garnered a $1 million loan from the state of Wisconsin and plans to relocate its headquarters from Massachusetts to Wisconsin, according to reports. News of the relocation comes three months after Exact announced that it had named a new CEO, Kevin Conroy, and new chief financial officer, Maneesh Arora. Conroy and Arora were previously CEO and CFO, respectively, at former molecular diagnostics firm Third Wave Technologies, of Madison, WI.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.

Comments | Reprints | Share: